Strength
100 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078024115
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
1/3/2020
Active Ingredients
CYCLOSPORINEApproval Type
New Drug (NDA)
FDA Application
NDA050625On Market Since
3/2/1990
Pharmacological Classes
Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors
Related Drugs
Same classification
TIAZAC ER 180 MG CAPSULE
Brand
00187261330•Bausch Health US LLC
$1.5060
per EA
TIAZAC ER 180 MG CAPSULE
Brand
00187261390•Bausch Health US LLC
$1.5060
per EA
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
ZONISADE 100 MG/5 ML ORAL SUSP
Brand
52652800101•Azurity Pharmaceuticals Inc.
$2.7530
per ML
TIAZAC ER 360 MG CAPSULE
Brand
00187261630•Bausch Health US LLC
$2.7628
per EA
TIAZAC ER 360 MG CAPSULE
Brand
00187261690•Bausch Health US LLC
$2.7628
per EA
ASTAGRAF XL 0.5 MG CAPSULE
Brand
00469064773•Astellas Pharma US, Inc.
$2.7786
per EA
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
CARDIZEM LA 120 MG TABLET
Brand
00187204530•Bausch Health US LLC
$3.6467
per EA
CARDIZEM LA 120 MG TABLET
Brand
00187204590•Bausch Health US LLC
$3.6467
per EA